tetano
Editor, Senior Moderator
Antimicrob Agents Chemother. 2020 Mar 23. pii: AAC.00483-20. doi: 10.1128/AAC.00483-20. [Epub ahead of print]
Updated approaches against SARS-CoV-2.
Li H[SUP]1,[/SUP][SUP]2[/SUP], Zhou Y[SUP]1,[/SUP][SUP]2[/SUP], Zhang M[SUP]1,[/SUP][SUP]2[/SUP], Wang H[SUP]1,[/SUP][SUP]2[/SUP], Zhao Q[SUP]1,[/SUP][SUP]2[/SUP], Liu J[SUP]3,[/SUP][SUP]2[/SUP].
Author information
Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing understanding of SARS-CoV-2 in the virology, epidemiology and clinical management strategies. However, no anti-SARS-CoV-2 drug or vaccine has been officially approved due to the absence of adequate evidence. Scientists are racing towards the development of treatment for COVID-19. Recent studies have revealed many attractive threptic options, even if some of them remain to be further confirmed in rigorous preclinical models and clinical trials. In this minireview, we aim to summarize the updated potential approaches against SARS-CoV-2. We emphasize that further efforts are warranted to develop the safest and most effective approach.
Copyright ? 2020 American Society for Microbiology.
PMID:32205349DOI:10.1128/AAC.00483-20
Updated approaches against SARS-CoV-2.
Li H[SUP]1,[/SUP][SUP]2[/SUP], Zhou Y[SUP]1,[/SUP][SUP]2[/SUP], Zhang M[SUP]1,[/SUP][SUP]2[/SUP], Wang H[SUP]1,[/SUP][SUP]2[/SUP], Zhao Q[SUP]1,[/SUP][SUP]2[/SUP], Liu J[SUP]3,[/SUP][SUP]2[/SUP].
Author information
Abstract
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing understanding of SARS-CoV-2 in the virology, epidemiology and clinical management strategies. However, no anti-SARS-CoV-2 drug or vaccine has been officially approved due to the absence of adequate evidence. Scientists are racing towards the development of treatment for COVID-19. Recent studies have revealed many attractive threptic options, even if some of them remain to be further confirmed in rigorous preclinical models and clinical trials. In this minireview, we aim to summarize the updated potential approaches against SARS-CoV-2. We emphasize that further efforts are warranted to develop the safest and most effective approach.
Copyright ? 2020 American Society for Microbiology.
PMID:32205349DOI:10.1128/AAC.00483-20